Sign in
Join
Discovery/Preclinical
In vitro
In vivo
Newer Targets
Clinical
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Commercial
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Sign up
Welcome!
Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
Search
Sign in / Join
Contact
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Create an account
Create an account
Welcome! Register for an account
your email
your username
A password will be e-mailed to you.
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Discovery/Preclinical
All
In vitro
In vivo
Newer Targets
Newer Targets
Gene therapy/gene editing combo could offer hope for some genetic disorders
Newer Targets
Researchers at Rush University Medical Center Find That Injecting Influenza Vaccines…
Newer Targets
Research Reveals Promising New Avenues for Anemia Treatment
Newer Targets
Novel discovery in gene therapy to treat kidney diseases …
Clinical
All
Approval
FDA/EMA/Drug Designation
IND
Launch
NDA
Phase I
Phase II
Phase III
Phase IV
Recall
Phase I
Atreca Announces First Patient Dosed in Phase 1b Clinical Trial of…
Clinical
Deciphera’s investigational GIST drug ripretinib granted priority review by FDA
Clinical
Eisai complies with FDA request to pull weight-loss drug Belviq from…
Clinical
FDA grants priority review to Bristol-Myers Squibb’s filing for liso-cel in…
Commercial
All
Acquisitions
Conference/Award
Deals
Financial
Lawsuits/Bankruptcy
Lay off/Spin-off/Appointments
Merger
Patent
Pricing
Commercial
Acerus Announces Private Placement and Refinancing Transactions
Commercial
Following Clinical Hold and Trial Setback, Ipsen Takes $728 Million Hit…
Commercial
Indivior Full Year 2019 Results Now Available; Leadership Presentation Today
Deals
Sensorion Announces the Full Conversion of Sofinnova Partners Convertible Bonds Into…
Home
Clinical
Phase III
Phase III
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Phase III
XTANDI (enzalutamide) Demonstrates Significant Improvement in Overall Survival in Phase 3 PROSPER Trial of Patients with nmCRPC
Firstwordpharma News
-
February 11, 2020
Phase III
Cytokinetics Announces Publication Relating to Design of GALACTIC-HF, a Phase 3 Clinical Trial of Omecamtiv Mecarbil in Patients With Heart Failure
Phase III
Rebiotix, a Ferring Company, Completes Enrollment for First-Ever, Pivotal Phase 3 Clinical Trial of Microbiota-based RBX2660
Phase III
Lilly and Incyte Announce Positive Top-Line Results from the North American (BREEZE-AD5) Phase 3 Study of Oral Selective JAK Inhibitor Baricitinib in Patients with...
Phase III
Bayer, Orion’s Nubeqa significantly improves overall survival in Phase III prostate cancer study
Phase III
Bayer, Orion’s Nubeqa significantly improves overall survival in Phase III prostate...
Firstwordpharma News
-
January 30, 2020
0
Phase III
Bausch Health and Clearside Biomedical Announce Publication of PIVOTAL Phase 3...
Firstwordpharma News
-
January 28, 2020
0
Phase III
Lilly and Incyte Announce Top-Line Results from Phase 3 Study of...
Biospace News
-
January 27, 2020
0
Phase III
Eli Lilly, Incyte’s JAK inhibitor Olumiant meets skin inflammation improvement goal...
Firstwordpharma News
-
January 27, 2020
0
Phase III
Ipsen Suspends Dosing in Phase III FOP Trial Following Futility Analysis
Biospace News
-
January 24, 2020
0
1
2
3
...
35
Page 1 of 35
- Advertisement -
MOST POPULAR
Seneca Biopharma Surges Near 113% After Comments on Seeking Partnership for...
January 17, 2020
Atriva Therapeutics Starts Clinical Development of Novel Host-Targeting Antiviral ATR-002 Against...
May 16, 2019
Personal Genome Diagnostics and Eisai Co., Ltd. Collaborate to Develop Comprehensive...
January 15, 2020
Navidea Biopharmaceuticals Announces Positive Results of First Interim Analysis of Ongoing...
October 29, 2019
Load more
HOT NEWS
Cardio-metabolism
ACC Roundup: Less Aspirin to Prevent Heart Attacks, Bristol-Myers & Pfizer,...
Commercial
Renal-Mass Biopsy Guided by Ultrasound Superior to CT-Guided Biopsy: Presented at...
Acquisitions
Merck to Acquire Immune Design
Commercial
Correvio Reports Third Quarter 2019 Financial Results
